Structures by: Wu Y. F.
Total: 17
C14H36Br10N4O2Pb3
C14H36Br10N4O2Pb3
CrystEngComm (2020)
a=11.3186(13)Å b=15.9262(17)Å c=11.5922(13)Å
α=90° β=118.5478(12)° γ=90°
0.5(Br20Pb6),2(C5H16N2)
0.5(Br20Pb6),2(C5H16N2)
CrystEngComm (2020)
a=20.368(3)Å b=8.0895(12)Å c=22.524(3)Å
α=90° β=114.5690(17)° γ=90°
C37H51N2O2,Cl4Fe
C37H51N2O2,Cl4Fe
Organic & biomolecular chemistry (2013) 11, 46 8135-8144
a=12.6980(6)Å b=16.1029(9)Å c=19.8555(9)Å
α=90.00° β=98.257(5)° γ=90.00°
C37H51N2O2,Br4Fe
C37H51N2O2,Br4Fe
Organic & biomolecular chemistry (2013) 11, 46 8135-8144
a=10.364(3)Å b=11.468(3)Å c=19.427(5)Å
α=93.341(2)° β=99.459(6)° γ=115.939(6)°
Br10Pb3,2(C6H18N2)
Br10Pb3,2(C6H18N2)
CrystEngComm (2020)
a=11.3799(8)Å b=14.9895(11)Å c=11.4899(8)Å
α=90° β=116.7445(8)° γ=90°
C18H12Cu2IN6S2
C18H12Cu2IN6S2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 45 17156-17162
a=7.360(4)Å b=17.468(9)Å c=17.955(9)Å
α=63.248(5)° β=82.315(6)° γ=86.261(6)°
C18H12Ag2N6O6S2,2(CH3CN)
C18H12Ag2N6O6S2,2(CH3CN)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 45 17156-17162
a=12.3349(4)Å b=14.6190(5)Å c=13.7257(5)Å
α=90.00° β=94.045(3)° γ=90.00°
C18H16Cl2CuN6O11
C18H16Cl2CuN6O11
Dalton transactions (Cambridge, England : 2003) (2014) 43, 45 17156-17162
a=12.3685(9)Å b=15.4917(12)Å c=12.9541(10)Å
α=90.00° β=111.2950(10)° γ=90.00°
2-(Methoxycarbonyl)anilinium chloride monohydrate
C8H10NO2,Cl,H2O
Acta Crystallographica Section E (2005) 61, 10 o3497-o3499
a=7.4709(9)Å b=11.6988(14)Å c=12.3883(15)Å
α=96.299(2)° β=101.097(2)° γ=106.844(2)°
N-Butyl 3,5-dinitrobenzoate
C11H12N2O6
Acta Crystallographica Section E (2005) 61, 12 o4173-o4174
a=9.681(3)Å b=5.8632(17)Å c=22.164(6)Å
α=90.00° β=90.826(5)° γ=90.00°
Methyl 5-bromosalicylate
C8H7BrO3
Acta Crystallographica Section E (2005) 61, 12 o4171-o4172
a=29.203(7)Å b=4.0724(10)Å c=16.679(4)Å
α=90.00° β=120.465(3)° γ=90.00°
5-Ethyl L-glutamate
C7H13NO4
Acta Crystallographica Section E (2005) 61, 12 o4028-o4029
a=9.691(3)Å b=5.2631(17)Å c=17.297(6)Å
α=90.00° β=90.752(5)° γ=90.00°
5-Methyl L-glutamate
C6H11NO4
Acta Crystallographica Section E (2005) 61, 11 o3752-o3753
a=10.286(3)Å b=4.6163(11)Å c=17.111(4)Å
α=90.00° β=104.995(4)° γ=90.00°
3-{[Bis(pyridin-2-ylmethyl)amino]methyl}-2-hydroxy-5-methylbenzaldehyde
C21H21N3O2
Acta Crystallographica Section E (2012) 68, 6 o1672-o1673
a=8.479(3)Å b=9.007(3)Å c=12.734(4)Å
α=107.565(4)° β=94.068(4)° γ=99.092(4)°
1(C70H12O3),CS2
1(C70H12O3),CS2
The Journal of organic chemistry (2019) 84, 19 12259-12267
a=10.1156(2)Å b=13.4679(3)Å c=28.2219(5)Å
α=90° β=89.999(2)° γ=90°
C75H14O3
C75H14O3
The Journal of organic chemistry (2019) 84, 19 12259-12267
a=16.7603(3)Å b=16.2554(2)Å c=27.9643(5)Å
α=90° β=90° γ=90°
C18H12ClCoN6O4S4,2(CH4O),H2O
C18H12ClCoN6O4S4,2(CH4O),H2O
Dalton transactions (Cambridge, England : 2003) (2014) 43, 45 17156-17162
a=18.573(16)Å b=18.573(16)Å c=31.35(5)Å
α=90.00° β=90.00° γ=90.00°